Molecular Templates, Inc. MTEM Income Statement

Molecular templates, inc. (MTEM)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Research and development revenue
-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total revenue
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total revenue
-	-	20,757	23,891	-	13,285	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Collaboration revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	65,874	69,554	73,234	76,915	14,722	14,722	14,722	14,722	14,253	13,754	13,254	12,495	11,304	9,920	8,537	5,867	0	0	0	-	-	0	-	-	-
Grant revenue
-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total revenue
-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating expenses:
Research and development
62,696	50,519	41,509	34,550	31,969	30,202	27,297	21,529	15,107	9,487	554	303	3,079	8,017	23,661	29,471	35,596	40,271	37,511	38,336	36,859	35,832	35,756	33,200	32,519	29,334	26,964	24,653	19,567	18,786	19,365	21,807	23,978	24,388	22,419	20,892	0	0	0
General and administrative
20,789	20,077	17,965	16,994	16,107	14,082	13,687	14,145	12,874	11,755	7,765	4,579	4,024	4,482	7,199	8,761	9,349	9,716	10,091	10,126	10,123	10,141	9,971	9,615	9,304	9,185	8,583	8,273	7,887	7,080	6,649	6,216	6,121	5,710	5,587	5,284	0	0	0
Loss on impairment of in-process research and development
-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
105,608	92,719	81,597	51,544	48,076	44,284	40,984	35,674	27,981	21,242	8,319	4,882	7,103	12,499	30,860	38,232	44,945	49,987	47,602	48,462	46,982	45,973	45,727	42,815	41,823	38,519	35,547	32,926	27,454	25,866	26,014	28,023	30,099	30,098	28,006	26,176	0	0	0
Loss from operations
-86,205	-70,449	-60,840	-27,653	-28,265	-30,999	-31,563	-32,357	-25,989	-17,847	-3,864	-1,075	-3,338	-10,619	35,014	31,322	28,289	26,928	-32,880	-33,740	-32,260	-31,251	-31,474	-29,061	-28,569	-26,024	-24,243	-23,006	-18,917	-19,999	-22,106	-25,912	-29,785	-30,036	-28,006	-26,176	0	0	0
Interest and other income, net
2,285	2,323	1,893	1,604	1,179	751	356	250	133	51	-57	-52	-13	19	104	125	124	125	123	123	114	121	129	136	140	136	129	124	0	-	0	0	-	-	-	-	-	-	-
Interest and other expense, net
1,353	1,298	1,265	1,191	988	990	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of warrant liabilities
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss before provision for income taxes
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest expense
-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other expense, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	16,686	17,119	18,711	16,769	902	246	6,315	9,344	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of warrant liabilities
-	-	38	41	-	951	1,313	1,037	741	128	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on conversion of notes
-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on conversion of notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest income (expense), net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	34	48	0	0	0
Other income (expense), net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	31,797	28,385	54,059	-51,216	-81,913	0	0	-	0	-	-	-	-
Income (loss) before provision for income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-28,213	7,683	5,499	35,257	-71,135	0	0	0	-	-	-	-	-	-
Provision for income taxes
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	202	0	0	0	-	-	-	0	-	-	-	-	-	-
Other income (expense)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0
Net loss
0	-	-	-	0	-	-	-	-	-23,140	-9,346	-1,571	-4,371	-11,028	51,805	48,566	47,124	43,822	-31,855	-33,169	-25,629	-21,584	-23,209	-14,288	-26,310	-28,415	7,562	5,395	35,184	-71,135	-103,648	-110,580	0	-	0	0	-	0	0
Deemed dividends on preferred stock
-	-	-	-	-	-	-	-	-	958	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest and other expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-
Net loss attributable to common shareholders
-85,271	-69,421	-60,174	-27,199	-27,741	-30,287	-30,568	-36,429	-31,190	-24,098	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Net loss per share attributable to common shareholders:
Basic
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	71,511	71,488	71,520	71,382	71,334	66,732	62,845	59,845	59,347	59,303	59,263	58,542	57,037	56,486	56,347	55,654	54,549	50,326	-	49,052	48,805	-	-	-
Diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	71,511	71,488	83,003	71,382	72,815	66,732	67,752	61,494	62,998	61,300	54,244	63,561	57,037	56,486	38,651	64,405	63,494	50,326	-	49,052	48,805	-	-	-
Basic and diluted
-0.48	-0.41	-1.03	-0.25	-0.17	-0.15	-0.19	-0.36	-0.32	26.83	-0.62	-20.76	-7.56	-	-11.89	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.23	-0.18	-0.01
Basic
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.10	-0.11	1.00	-0.09	-0.12	-0.17	-0.10	-0.13	-0.01	-0.12	-0.13	0.02	-0.22	-0.16	0.70	-0.02	0.31	-2.30	-	-0.08	-0.16	-	-	-
Diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.10	-0.11	0.92	-0.09	-0.12	-0.17	-0.08	-0.15	-0.12	-0.14	-0.03	-0.08	-0.22	-0.16	1.09	-0.06	-0.04	-2.30	-	-0.08	-0.16	-	-	-
Weighted average number of shares used in net loss per share calculations:
Basic and diluted
45,649	40,584	36,937	36,819	36,738	36,674	27,680	27,062	26,989	27,248	17,925	214	214	-	301	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss attributable to common shareholders
-85,271	-69,421	-60,174	-27,199	-27,741	-30,287	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other comprehensive loss:
Unrealized gain (loss) on available-for-sale securities
-	-	-	-	-	-	-	-	0	0	-26	-26	-22	0	8	23	16	-8	-7	-35	-28	-41	-34	44	7	17	24	-14	5	12	23	-11	4	-2	0	0	0	-	-
Comprehensive loss
-	-	-	-	-	-	-	-	-31,190	-24,098	-11,508	-3,988	-6,392	-12,600	51,420	48,589	47,140	43,814	-31,862	-33,204	-25,657	-21,625	-23,243	-14,244	-26,303	-28,398	7,586	5,381	35,189	-71,123	-104,775	-107,943	-132,852	-25,655	0	0	0	-	-
Weighted average number of shares used in per common share calculations: basic and diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	36,445	33,672	33,638
Grant
Total revenue
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total revenue
-	-	1,869	6,159	-	6,002	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-